Treating Opioid Use Disorders in Drug Court: Participants’ Views on Using Medication-Assisted Treatments (MATs) to Support Recovery

Abstract

Drug courts began in 1989 in Miami-Dade County, FL. Due to their success in treating substance use disorders and reducing criminal recidivism, they have expanded globally and are currently operating in countries such as Australia, Canada, and Scotland, to name a few. Drug courts can be a key intervention in addressing the opioid epidemic. This is the first known qualitative study to ask drug court participants (n = 38) who have opioid use disorders questions related to their lived experiences in drug court, as well as direct questions related to the use of medication-assisted treatments (MATs) in drug court. Overall, drug court participants felt that MATs were helpful for treating their opioid use disorders; however, some participants reported using other drugs while on MATs and they viewed their recovery through a harm reduction lens. Additionally, participants emphasized the importance of using MATs in combination with counseling that used cognitive and behavioral therapies. Implications for drug court practice and future research are discussed.

Keywords

drug court harm reduction medication-assisted treatment opioid use disorder qualitative research

Get full access to this article

View all access options for this article.

References

American College of Obstetricians and Gynecologists. (2017). ACOG committee opinion number 711, August 2017. Washington, DC: Author. Retrieved from https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Opioid-Use-and-Opioid-Use-Disorder-in-Pregnancy?IsMobileSet=false

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: Author.

Bronson

Stroop

Zimmer

Berzofsky

(2017). Drug use, dependence, and abuse among state prisoners and jail inmates, 2007–2009. Washington, DC: U.S. Department of Justice.

Brown

(2011). Drug court effectiveness: A matched cohort study in the Dane county drug treatment court. Journal of Offender Rehabilitation, 50, 191–201.

Center for Disease Control and Prevention. (2017). Annual surveillance report of drug-related risks and outcomes—United States, 2017. Retrieved from https://www.cdc.gov/drugoverdose/pdf/pubs/2017-cdc-drug-surveillance-report.pdf

The Council of Economic Advisors. (2017). The underestimated cost of the opioid crisis. Washington, DC: Executive Office of the President of the United States.

Friedmann

P. D.

Hoskinson

Jr Gordon

Schwartz

Kinlock

Knight

… Frisman

L. K

. (2012). Medication-assisted treatment in criminal justice agencies affiliated with the Criminal Justice-Drug Abuse Treatment Atudies (CJ-DATS): Availability, barriers, and intentions. Substance Abuse, 33, 9–18.

Gallagher

J. R.

(2013). Drug court graduation rates: Implications for policy advocacy and future research. Alcoholism Treatment Quarterly, 31, 241–253.

Gallagher

J. R.

Marlowe

D. B.

Minasian

R. M.

(2019). Participant perspectives on medication-assisted treatment for opioid use disorders in drug court. Manuscript submitted for publication.

10.

Gallagher

J. R.

Nordberg

(2017). A phenomenological and grounded theory study of women’s experiences in drug court: Informing practice through a gendered lens. Women & Criminal Justice, 27, 327–340.

11.

Gallagher

J. R.

Nordberg

(2018). African American participants’ suggestions for eliminating racial disparities in graduation rates: Implications for drug court practice. Journal for Advancing Justice, 1, 89–107.

12.

Gallagher

J. R.

Nordberg

Deranek

M. S.

Ivory

Carlton

Woodward Miller

(2015). Predicting termination from drug court and comparing recidivism patterns: Treating substance use disorders in criminal justice settings. Alcoholism Treatment Quarterly, 33, 28–43.

13.

Gallagher

J. R.

Nordberg

Gallagher

J. M.

(2018). Participants’ views on the strengths and limitations of drug court: Recommendations to enhance assessment and treatment of mental illnesses. Social Work in Mental Health, 16, 436–450.

14.

Gallagher

J. R.

Nordberg

Lefebvre

(2017). Improving graduation rates in drug court: A qualitative study of participants’ lived experiences. Criminology and Criminal Justice, 17, 468–484.

15.

Gallagher

J. R.

Wahler

E. A.

(2018). Racial disparities in drug court graduation rates: The role of recovery support groups and environments. Journal of Social Work Practice in the Addictions, 18, 113–127.

16.

Gallagher

J. R.

Wahler

E. A.

Lefebvre

Paiano

Carlton

Woodward Miller

(2018). Improving graduation rates in drug court through employment and schooling opportunities and medication-assisted treatment (MAT). Journal of Social Service Research, 44, 343–349.

17.

Gallagher

J. R.

Whitmore

T. D.

Horsley

Marshall

Deranek

Callantine

Woodward Miller

. (2019). A perspective from the field: Five interventions to combat the opioid epidemic and ending the dichotomy of harm reduction versus abstinence-based programs. Alcoholism Treatment Quarterly, 37, 404–417.

18.

Gill

M. E.

(2016). Predictors of drug court client graduation. Journal of Offender Rehabilitation, 55, 564–588.

19.

Gottfredson

D. C.

Exum

M. L.

(2002). The Baltimore City drug treatment court: One-year results from a randomized study. Journal of Research in Crime and Delinquency, 39, 337–356.

20.

Gottfredson

D. C.

Najaka

S. S.

Kearley

(2003). Effectiveness of drug treatment courts: Evidence from a randomized trial. Criminology and Public Policy, 2, 171–196.

21.

Holst

K. Y. W.

(2010). A good score? Examining twenty years of drug courts in the United States and abroad. Valparaiso University Law Review, 45, 73–106.

22.

Kampman

Jarvis

(2015). American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use. Journal of Addiction Medicine, 9, 358–367.

23.

Knopf

(2015). SAMHSA-funded drug courts can’t order patients off meds. Alcoholism & Drug Abuse Weekly, 27, 4–6.

24.

Loughran

Hohman

Carolan

Bloomfield

(2015). Practice note: The Irish drug treatment court. Alcoholism Treatment Quarterly, 33, 82–92.

25.

Matusow

Dickman

S. L.

Rich

J. D.

Fong

Dumont

D. M.

Hardin

… Rosenblum

. (2013). Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes. Journal of Substance Abuse Treatment, 44, 473–480.

26.

Mehta

Møllmann

(2017). Neither justice nor treatment: Drug courts in the United States. Washington, DC: Physicians for Human Rights.

27.

Miles

M. B.

Huberman

A. M.

Saldana

(2014). Qualitative data analysis: A methods sourcebook (3rd ed.). Thousand Oaks, CA: Sage.

28.

Mitchell

Wilson

D. B.

Eggers

MacKenzie

D. L.

(2012). Assessing the effectiveness of drug courts on recidivism: A meta-analytic review of traditional and non-traditional drug courts. Journal of Criminal Justice, 40, 60–71.

29.

National Association of Drug Court Professionals. (2004). Defining drug courts: The key components. Retrieved from https://www.ncjrs.gov/pdffiles1/bja/205621.pdf

30.

National Association of Drug Court Professionals. (2018). Adult drug court best practice standards (Vol. I: Text Revision). Alexandria, VA: Author.

31.

National Institute on Drug Abuse. (2018). Effective treatments for opioid addiction. Rockville, MD: Author. Retrieved from https://www.drugabuse.gov/publications/effective-treatments-opioid-addiction/effective-treatments-opioid-addiction

32.

Padgett

D. K.

(2016). Qualitative methods in social work research (3rd ed.). Thousand Oaks, CA: Sage.

33.

Rubin

Babbie

E. R.

(2008). Research methods for social work (6th ed.). Belmont, CA: Thomson Brooks/Cole.

34.

Rudd

R. A.

Seth

David

Scholl

(2016). Increases in drug and opioid-involved overdose deaths—United States, 2010–2015. Morbidity and Mortality Weekly Report, 65, 1445–1452.

35.

The Sentencing Project. (2018). Trends in U.S. corrections. Retrieved from http://www.sentencingproject.org/publications/trends-in-u-s-corrections/

36.

Shaffer

D. K.

(2011). Looking inside the black box of drug courts: A meta-analytic review. Justice Quarterly, 28, 493–521.

37.

Shaffer

D. K.

Hartman

J. L.

Listwan

S. J.

Howell

Latessa

E. J.

(2011). Outcomes among drug court participants: Does drug of choice matter? International Journal of Offender Therapy and Comparative Criminology, 55, 155–174.

38.

Substance Abuse and Mental Health Services Administration. (2018). Medications for opioid use disorder. Treatment Improvement Protocol (TIP) Series 63, Executive Summary. HHS Publication No. (SMA) 18-5063EXSUMM. Rockville, MD: Author.

39.

U.S. Department of Health and Human Services [HHS]. (2017). Secretary Price announces HHS strategy for fighting opioid crisis. Retrieved from https://www.hhs.gov/about/leadership/secretary/speeches/2017-speeches/secretary-price-announces-hhs-strategy-for-fighting-opioid-crisis/index.html

40.

U.S. Department of Health and Human Services [HHS]. (2018). What is the U.S. opioid epidemic? Retrieved from https://www.hhs.gov/opioids/about-the-epidemic/index.html

41.

U.S. Department of Justice, Office of Justice Programs. (2018). Drug courts. Retrieved from https://www.ncjrs.gov/pdffiles1/nij/238527.pdf

42.

Vandermause

Severtsen

Roll

(2013). Re-creating a vision of motherhood: Therapeutic drug court and the narrative. Qualitative Social Work, 12, 620–636.

43.

Volkow

N. D.

(2014). Testimony to congress: Prescription opioid and heroin abuse. Retrieved from https://www.drugabuse.gov/about-nida/legislative-activities/testimony-to-congress/2015/prescription-opioid-heroin-abuse